Abstract
Tuberculosis represents the main cause of mortality due to a single pathogen infection. Advances in anti-tuberculosis therapies are urgently required both for treatment of the 8-12 million new cases of tuberculosis leading to 2 million deaths each year, as well as for the 2 billion individuals already infected with M. tuberculosis, who are at the risk of developing disease. The present review summarizes the actually available information about currently existing therapies and perspectives for future innovative therapeutic approaches.
Keywords: tuberculosis, mycobacteria, therapeutics, immune-modulators
Letters in Drug Design & Discovery
Title: Tuberculosis Therapeutics: Past Achievements, Present Road-Blocks and Future Perspectives
Volume: 1 Issue: 4
Author(s): Sanjay K. Garg, Marilina B. Santucci, Fouad Seghrouchni, Cesare Saltini, Prakash S. Bisen, Vittorio Colizzi and Maurizio Fraziano
Affiliation:
Keywords: tuberculosis, mycobacteria, therapeutics, immune-modulators
Abstract: Tuberculosis represents the main cause of mortality due to a single pathogen infection. Advances in anti-tuberculosis therapies are urgently required both for treatment of the 8-12 million new cases of tuberculosis leading to 2 million deaths each year, as well as for the 2 billion individuals already infected with M. tuberculosis, who are at the risk of developing disease. The present review summarizes the actually available information about currently existing therapies and perspectives for future innovative therapeutic approaches.
Export Options
About this article
Cite this article as:
Garg K. Sanjay, Santucci B. Marilina, Seghrouchni Fouad, Saltini Cesare, Bisen S. Prakash, Colizzi Vittorio and Fraziano Maurizio, Tuberculosis Therapeutics: Past Achievements, Present Road-Blocks and Future Perspectives, Letters in Drug Design & Discovery 2004; 1 (4) . https://dx.doi.org/10.2174/1570180043398515
DOI https://dx.doi.org/10.2174/1570180043398515 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Computational Enzymology and Organophosphorus Degrading Enzymes: Promising Approaches Toward Remediation Technologies of Warfare Agents and Pesticides
Current Medicinal Chemistry Abiotic Regulation: A Common Way for Proteins to Modulate their Functions
Current Protein & Peptide Science Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Shikimate Kinase, a Protein Target for Drug Design
Current Medicinal Chemistry Exploiting Microwave-Assisted Organic Synthesis (MAOS) for Accessing Bioactive Scaffolds
Current Organic Chemistry Role of Lipopolysaccharides in Potential Applications of Nanocarrier Systems
Current Pharmaceutical Design NMN/NaMN Adenylyltransferase (NMNAT) and NAD Kinase (NADK) Inhibitors: Chemistry and Potential Therapeutic Applications
Current Medicinal Chemistry Editorial [Hot Topic: Nucleoside and Nucleotide Therapeutics: Recent Targets in Medicinal Chemistry (Guest Editor: Claire Simons)]
Current Topics in Medicinal Chemistry Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against <i>M. tuberculosis</i> Enzyme Targets
Current Topics in Medicinal Chemistry Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
Current Drug Targets SCYPPred: A Web-Based Predictor of SNPs for Human Cytochrome P450
Protein & Peptide Letters Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Truncated Human Cathepsin L, Encoded by a Novel Splice Variant, Exhibits Altered Subcellular Localization and Cytotoxicity
Protein & Peptide Letters Nanoemulsion for the Effective Treatment and Management of Anti-tubercular Drug Therapy
Recent Patents on Anti-Infective Drug Discovery Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria
Current Topics in Medicinal Chemistry Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism Alcohol Abuse and HIV Infection: Role of DRD2
Current HIV Research Epidemiology of Candida albicans Infections and Role of Non-Candidaalbicans Yeasts
Current Drug Targets Enantioselective Organocatalytic Reactions with Isatin
Current Organic Chemistry Molecular Hybridization and Preclinical Evaluation of Imines From Para-substituted 4-phenyl 2-amino Thiazole Incorporated with Isatin Analogues as Antitubercular Agents
Anti-Infective Agents